Shares in Celcuity climbed by 233.76% at market open on 28 July after it reported the Phase III breast cancer data.

A team of Toronto researchers has received Health Canada approval to conduct clinical trials for a novel class of ...

Cancer remains one of the most relentless challenges in modern medicine. In 2025, over 2 million new cancer cases are expected to be diagnosed in the United States. More than 618,000 people will die ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $100 million milestone payment from ...

A research project led by the Ineos Oxford Institute for antimicrobial research (IOI) to study the cause and impact of ...

Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

The new drug forces fat cells to produce more energy and doesn't impact appetite or muscle mass, unlike some existing ...

Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...

A team of researchers has recently developed a nondestructive imaging and machine learning system that accurately predicts ...